Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Robert P. Giugliano
Based on 11 articles published since 2007
||||
Expertise Level
The expertise of Robert P. Giugliano ranks in the
  • Top 0.12%
  • ... of 29,430 published authors worldwide on Hypercholesterolemia
  • ... from 2007 through 2018
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Harvard University   Contact    
2017
  • Brigham and Women’s Hospital, Boston, MA · · Warren Alpert Medical School of Brown University, Providence, RI · Pubmed 29141161
2014
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
2012
  • TIMI Study Group, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 23141813
2017
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W., S.A.M., J.F.K.); Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); Amgen, Thousand Oaks, CA (N.H., H.W., T.L., S.M.W.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London (P.S.S.); and Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo (T.R.P.). · Pubmed 28304224
2015
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.); the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa; the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.); the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.); Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott); Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
2014
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.); Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.); Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.); Bethesda Health Research Center, Bethesda, MD (M.B.); Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.); Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.); and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
2013
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23884353
2012
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 22714699
2010
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 20400493
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Robert P. Giugliano about Hypercholesterolemia:

  • Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. 2017
  • Cognitive Function in a Randomized Trial of Evolocumab. 2017
  • Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. 2015
  • AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57). 2014
  • Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. 2014
  • Does it make sense to combine statins with other lipid-altering agents following AIM-HIGH, SHARP and ACCORD? 2013
  • AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial. 2013
  • Cholesterol levels and the association of statins with in-hospital mortality of myocardial infarction patients insights from a Chilean registry of myocardial infarction. 2013
  • Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study. 2012
  • Design and rationale of the LAPLACE-TIMI 57 trial: a phase II, double-blind, placebo-controlled study of the efficacy and tolerability of a monoclonal antibody inhibitor of PCSK9 in subjects with hypercholesterolemia on background statin therapy. 2012
Show List of Full Article Records
Google Searches

Learn more about Robert P. Giugliano using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University
2017
  • Brigham and Women’s Hospital, Boston, MA · · Warren Alpert Medical School of Brown University, Providence, RI · Pubmed 29141161
2014
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
2012
  • TIMI Study Group, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 23141813
2017
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W., S.A.M., J.F.K.); Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); Amgen, Thousand Oaks, CA (N.H., H.W., T.L., S.M.W.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London (P.S.S.); and Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo (T.R.P.). · Pubmed 28304224
2015
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.); the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa; the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.); the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.); Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott); Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
2014
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.); Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.); Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.); Bethesda Health Research Center, Bethesda, MD (M.B.); Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.); Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.); and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
2013
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23884353
2012
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 22714699
2010
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 20400493
15 Other Locations Show
Yearly article counts 020123201000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.